 | • レポートコード：MRC2012A0544 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗うつ薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗うつ薬の種類別市場規模（選択的セロトニン再取り込み阻害薬（SSRI）、セロトニン・ノルアドレナリン再取り込み阻害薬（SNRI）、三環系抗うつ薬（TCA）、モノアミン酸化酵素阻害薬（MAOI）、その他）、用途別市場規模（大うつ病性障害、強迫性障害、全般性不安障害、パニック障害、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Alkermes、Pfizer、Eli Lilly and Company、Allergan、Merck、Bristol-Myers Squibb、Takeda Pharmaceutical Company、Lundbeck、GlaxoSmithKline、Teva Pharmaceutical Industries、AstraZeneca、Sun Pharmaceuticals、Johnson and Johnson、Sanofi、 ・地域別グローバル市場分析 2015年-2020年 ・抗うつ薬の北米市場（アメリカ、カナダ、メキシコ） ・抗うつ薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗うつ薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗うつ薬の南米市場（ブラジル、アルゼンチン） ・抗うつ薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：選択的セロトニン再取り込み阻害薬（SSRI）、セロトニン・ノルアドレナリン再取り込み阻害薬（SNRI）、三環系抗うつ薬（TCA）、モノアミン酸化酵素阻害薬（MAOI）、その他 ・用途別分析：大うつ病性障害、強迫性障害、全般性不安障害、パニック障害、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Anti-depressant Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Anti-depressant Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 13400 million by 2025, from USD 12810 million in 2019.
Market segmentation
Anti-depressant Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti-depressant Drugs market has been segmented into
Selective Serotonin Reuptake Inhibitor (SSRI)
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Tricyclic Antidepressant (TCA)
Monoamine Oxidase Inhibitor (MAOI)
Others
By Application, Anti-depressant Drugs has been segmented into:
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-depressant Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-depressant Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-depressant Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Anti-depressant Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti-depressant Drugs Market Share Analysis
Anti-depressant Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-depressant Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-depressant Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Anti-depressant Drugs are:
Alkermes
Pfizer
Eli Lilly and Company
Allergan
Merck
Bristol-Myers Squibb
Takeda Pharmaceutical Company
Lundbeck
GlaxoSmithKline
Teva Pharmaceutical Industries
AstraZeneca
Sun Pharmaceuticals
Johnson and Johnson
Sanofi
Among other players domestic and global, Anti-depressant Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-depressant Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-depressant Drugs, with price, sales, revenue and global market share of Anti-depressant Drugs in 2018 and 2019.
Chapter 3, the Anti-depressant Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-depressant Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anti-depressant Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anti-depressant Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Anti-depressant Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-depressant Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Selective Serotonin Reuptake Inhibitor (SSRI)
1.2.3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
1.2.4 Tricyclic Antidepressant (TCA)
1.2.5 Monoamine Oxidase Inhibitor (MAOI)
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-depressant Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Major Depressive Disorder
1.3.3 Obsessive-Compulsive Disorder
1.3.4 Generalized Anxiety Disorder
1.3.5 Panic Disorder
1.3.6 Others
1.4 Overview of Global Anti-depressant Drugs Market
1.4.1 Global Anti-depressant Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alkermes
2.1.1 Alkermes Details
2.1.2 Alkermes Major Business
2.1.3 Alkermes SWOT Analysis
2.1.4 Alkermes Product and Services
2.1.5 Alkermes Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly and Company
2.3.1 Eli Lilly and Company Details
2.3.2 Eli Lilly and Company Major Business
2.3.3 Eli Lilly and Company SWOT Analysis
2.3.4 Eli Lilly and Company Product and Services
2.3.5 Eli Lilly and Company Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Product and Services
2.6.4 Bristol-Myers Squibb Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda Pharmaceutical Company
2.7.1 Takeda Pharmaceutical Company Details
2.7.2 Takeda Pharmaceutical Company Major Business
2.7.3 Takeda Pharmaceutical Company Product and Services
2.7.4 Takeda Pharmaceutical Company Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lundbeck
2.8.1 Lundbeck Details
2.8.2 Lundbeck Major Business
2.8.3 Lundbeck Product and Services
2.8.4 Lundbeck Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline Product and Services
2.9.4 GlaxoSmithKline Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries Product and Services
2.10.4 Teva Pharmaceutical Industries Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Product and Services
2.11.4 AstraZeneca Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sun Pharmaceuticals
2.12.1 Sun Pharmaceuticals Details
2.12.2 Sun Pharmaceuticals Major Business
2.12.3 Sun Pharmaceuticals Product and Services
2.12.4 Sun Pharmaceuticals Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Johnson and Johnson
2.13.1 Johnson and Johnson Details
2.13.2 Johnson and Johnson Major Business
2.13.3 Johnson and Johnson Product and Services
2.13.4 Johnson and Johnson Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Product and Services
2.14.4 Sanofi Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti-depressant Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti-depressant Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-depressant Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-depressant Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti-depressant Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-depressant Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti-depressant Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti-depressant Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Anti-depressant Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-depressant Drugs Sales and Growth Rate (2015-2020)
4.5 South America Anti-depressant Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti-depressant Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti-depressant Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anti-depressant Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-depressant Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Anti-depressant Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Anti-depressant Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Anti-depressant Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti-depressant Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-depressant Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti-depressant Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti-depressant Drugs Sales and Growth Rate (2015-2020)
6.3 UK Anti-depressant Drugs Sales and Growth Rate (2015-2020)
6.4 France Anti-depressant Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Anti-depressant Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Anti-depressant Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-depressant Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti-depressant Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti-depressant Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Anti-depressant Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Anti-depressant Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Anti-depressant Drugs Sales and Growth Rate (2015-2020)
7.5 India Anti-depressant Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-depressant Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Anti-depressant Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti-depressant Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anti-depressant Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti-depressant Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti-depressant Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Anti-depressant Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-depressant Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti-depressant Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti-depressant Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti-depressant Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Anti-depressant Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-depressant Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Anti-depressant Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti-depressant Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Anti-depressant Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Anti-depressant Drugs Price by Type (2015-2020)
11 Global Anti-depressant Drugs Market Segment by Application
11.1 Global Anti-depressant Drugs Sales Market Share by Application (2015-2020)
11.2 Global Anti-depressant Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Anti-depressant Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti-depressant Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti-depressant Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Anti-depressant Drugs Market Forecast (2021-2025)
12.2.2 Europe Anti-depressant Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti-depressant Drugs Market Forecast (2021-2025)
12.2.4 South America Anti-depressant Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti-depressant Drugs Market Forecast (2021-2025)
12.3 Anti-depressant Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Anti-depressant Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Anti-depressant Drugs Market Share Forecast by Type (2021-2025)
12.4 Anti-depressant Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Anti-depressant Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Anti-depressant Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anti-depressant Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-depressant Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-depressant Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Anti-depressant Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Alkermes Basic Information, Manufacturing Base and Competitors
Table 9. Alkermes Anti-depressant Drugs Major Business
Table 10. Alkermes Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Alkermes SWOT Analysis
Table 12. Alkermes Anti-depressant Drugs Product and Services
Table 13. Alkermes Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Pfizer Basic Information, Manufacturing Base and Competitors
Table 15. Pfizer Anti-depressant Drugs Major Business
Table 16. Pfizer Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 17. Pfizer SWOT Analysis
Table 18. Pfizer Anti-depressant Drugs Product and Services
Table 19. Pfizer Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 21. Eli Lilly and Company Anti-depressant Drugs Major Business
Table 22. Eli Lilly and Company Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 23. Eli Lilly and Company SWOT Analysis
Table 24. Eli Lilly and Company Anti-depressant Drugs Product and Services
Table 25. Eli Lilly and Company Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Allergan Basic Information, Manufacturing Base and Competitors
Table 27. Allergan Anti-depressant Drugs Major Business
Table 28. Allergan Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Allergan SWOT Analysis
Table 30. Allergan Anti-depressant Drugs Product and Services
Table 31. Allergan Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Merck Basic Information, Manufacturing Base and Competitors
Table 33. Merck Anti-depressant Drugs Major Business
Table 34. Merck Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 35. Merck SWOT Analysis
Table 36. Merck Anti-depressant Drugs Product and Services
Table 37. Merck Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers Squibb Anti-depressant Drugs Major Business
Table 40. Bristol-Myers Squibb Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 41. Bristol-Myers Squibb SWOT Analysis
Table 42. Bristol-Myers Squibb Anti-depressant Drugs Product and Services
Table 43. Bristol-Myers Squibb Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 45. Takeda Pharmaceutical Company Anti-depressant Drugs Major Business
Table 46. Takeda Pharmaceutical Company Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 47. Takeda Pharmaceutical Company SWOT Analysis
Table 48. Takeda Pharmaceutical Company Anti-depressant Drugs Product and Services
Table 49. Takeda Pharmaceutical Company Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 51. Lundbeck Anti-depressant Drugs Major Business
Table 52. Lundbeck Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 53. Lundbeck SWOT Analysis
Table 54. Lundbeck Anti-depressant Drugs Product and Services
Table 55. Lundbeck Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 57. GlaxoSmithKline Anti-depressant Drugs Major Business
Table 58. GlaxoSmithKline Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 59. GlaxoSmithKline SWOT Analysis
Table 60. GlaxoSmithKline Anti-depressant Drugs Product and Services
Table 61. GlaxoSmithKline Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 63. Teva Pharmaceutical Industries Anti-depressant Drugs Major Business
Table 64. Teva Pharmaceutical Industries Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 65. Teva Pharmaceutical Industries SWOT Analysis
Table 66. Teva Pharmaceutical Industries Anti-depressant Drugs Product and Services
Table 67. Teva Pharmaceutical Industries Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 69. AstraZeneca Anti-depressant Drugs Major Business
Table 70. AstraZeneca Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 71. AstraZeneca SWOT Analysis
Table 72. AstraZeneca Anti-depressant Drugs Product and Services
Table 73. AstraZeneca Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 75. Sun Pharmaceuticals Anti-depressant Drugs Major Business
Table 76. Sun Pharmaceuticals Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 77. Sun Pharmaceuticals SWOT Analysis
Table 78. Sun Pharmaceuticals Anti-depressant Drugs Product and Services
Table 79. Sun Pharmaceuticals Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 81. Johnson and Johnson Anti-depressant Drugs Major Business
Table 82. Johnson and Johnson Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 83. Johnson and Johnson SWOT Analysis
Table 84. Johnson and Johnson Anti-depressant Drugs Product and Services
Table 85. Johnson and Johnson Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Sanofi Basic Information, Manufacturing Base and Competitors
Table 87. Sanofi Anti-depressant Drugs Major Business
Table 88. Sanofi Anti-depressant Drugs Total Revenue (USD Million) (2018-2019)
Table 89. Sanofi SWOT Analysis
Table 90. Sanofi Anti-depressant Drugs Product and Services
Table 91. Sanofi Anti-depressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Global Anti-depressant Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 93. Global Anti-depressant Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 94. Global Anti-depressant Drugs Sales by Regions (2015-2020) (K Units)
Table 95. Global Anti-depressant Drugs Sales Market Share by Regions (2015-2020)
Table 96. Global Anti-depressant Drugs Revenue by Regions (2015-2020) (USD Million)
Table 97. North America Anti-depressant Drugs Sales by Countries (2015-2020) (K Units)
Table 98. North America Anti-depressant Drugs Sales Market Share by Countries (2015-2020)
Table 99. North America Anti-depressant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 100. North America Anti-depressant Drugs Revenue Market Share by Countries (2015-2020)
Table 101. Europe Anti-depressant Drugs Sales by Countries (2015-2020) (K Units)
Table 102. Europe Anti-depressant Drugs Sales Market Share by Countries (2015-2020)
Table 103. Europe Anti-depressant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 104. Asia-Pacific Anti-depressant Drugs Sales by Regions (2015-2020) (K Units)
Table 105. Asia-Pacific Anti-depressant Drugs Sales Market Share by Regions (2015-2020)
Table 106. Asia-Pacific Anti-depressant Drugs Revenue by Regions (2015-2020) (USD Million)
Table 107. South America Anti-depressant Drugs Sales by Countries (2015-2020) (K Units)
Table 108. South America Anti-depressant Drugs Sales Market Share by Countries (2015-2020)
Table 109. South America Anti-depressant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 110. South America Anti-depressant Drugs Revenue Market Share by Countries (2015-2020)
Table 111. Middle East & Africa Anti-depressant Drugs Sales by Countries (2015-2020) (K Units)
Table 112. Middle East & Africa Anti-depressant Drugs Sales Market Share by Countries (2015-2020)
Table 113. Middle East & Africa Anti-depressant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 114. Middle East & Africa Anti-depressant Drugs Revenue Market Share by Countries (2015-2020)
Table 115. Global Anti-depressant Drugs Sales by Type (2015-2020) (K Units)
Table 116. Global Anti-depressant Drugs Sales Share by Type (2015-2020)
Table 117. Global Anti-depressant Drugs Revenue by Type (2015-2020) (USD Million)
Table 118. Global Anti-depressant Drugs Revenue Share by Type (2015-2020)
Table 119. Global Anti-depressant Drugs Sales by Application (2015-2020) (K Units)
Table 120. Global Anti-depressant Drugs Sales Share by Application (2015-2020)
Table 121. Global Anti-depressant Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 122. Global Anti-depressant Drugs Market Share Forecast by Regions (2021-2025)
Table 123. Global Anti-depressant Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 124. Global Anti-depressant Drugs Market Share Forecast by Type (2021-2025)
Table 125. Global Anti-depressant Drugs Sales Forecast by Application (2021-2025)
Table 126. Global Anti-depressant Drugs Market Share Forecast by Application (2021-2025)
Table 127. Direct Channel Pros & Cons
Table 128. Indirect Channel Pros & Cons
Table 129. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anti-depressant Drugs Picture
Figure 2. Global Sales Market Share of Anti-depressant Drugs by Type in 2019
Figure 3. Selective Serotonin Reuptake Inhibitor (SSRI) Picture
Figure 4. Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Picture
Figure 5. Tricyclic Antidepressant (TCA) Picture
Figure 6. Monoamine Oxidase Inhibitor (MAOI) Picture
Figure 7. Others Picture
Figure 8. Anti-depressant Drugs Sales Market Share by Application in 2019
Figure 9. Major Depressive Disorder Picture
Figure 10. Obsessive-Compulsive Disorder Picture
Figure 11. Generalized Anxiety Disorder Picture
Figure 12. Panic Disorder Picture
Figure 13. Others Picture
Figure 14. Global Anti-depressant Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Anti-depressant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Anti-depressant Drugs Sales Market Share by Manufacturer in 2019
Figure 35. Global Anti-depressant Drugs Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Anti-depressant Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Anti-depressant Drugs Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 40. Global Anti-depressant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Anti-depressant Drugs Revenue Market Share by Regions (2015-2020)
Figure 42. Global Anti-depressant Drugs Revenue Market Share by Regions in 2018
Figure 43. North America Anti-depressant Drugs Sales and Growth Rate (2015-2020)
Figure 44. Europe Anti-depressant Drugs Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Anti-depressant Drugs Sales and Growth Rate (2015-2020)
Figure 46. South America Anti-depressant Drugs Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Anti-depressant Drugs Sales and Growth Rate (2015-2020)
Figure 48. North America Anti-depressant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Anti-depressant Drugs Sales Market Share by Countries (2015-2020)
Figure 50. North America Anti-depressant Drugs Sales Market Share by Countries in 2018
Figure 51. North America Anti-depressant Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Anti-depressant Drugs Revenue Market Share by Countries in 2018
Figure 53. United States Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Canada Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Mexico Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Europe Anti-depressant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Anti-depressant Drugs Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Anti-depressant Drugs Revenue Market Share by Countries in 2019
Figure 59. Germany Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. UK Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. France Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Russia Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Italy Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Asia-Pacific Anti-depressant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Anti-depressant Drugs Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Anti-depressant Drugs Revenue Market Share by Regions 2019
Figure 67. China Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Japan Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Korea Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. India Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Southeast Asia Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. South America Anti-depressant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Anti-depressant Drugs Sales Market Share by Countries in 2019
Figure 74. South America Anti-depressant Drugs Revenue Market Share by Countries in 2019
Figure 75. Brazil Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Argentina Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Middle East and Africa Anti-depressant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Anti-depressant Drugs Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Anti-depressant Drugs Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Anti-depressant Drugs Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Egypt Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Turkey Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 84. South Africa Anti-depressant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Global Anti-depressant Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 86. Global Anti-depressant Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Anti-depressant Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Europe Sales Anti-depressant Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Asia-Pacific Sales Anti-depressant Drugs Market Forecast (2021-2025) (K Units)
Figure 90. South America Sales Anti-depressant Drugs Market Forecast (2021-2025) (K Units)
Figure 91. Middle East & Africa Sales Anti-depressant Drugs Market Forecast (2021-2025) (K Units)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
抗うつ剤の世界市場（～2026年） Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperact…- 神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…
- 流動点降下剤の世界市場（～2026年） Pour point depressants are used to allow the use of petroleum based mineral oils at lower temperatures. The lowest temperature at which a fuel or oil will pour is called a pour point. Wax crystals, which form at lower temperatures, may interfere with lubrication of mechanical equipment. High-quality…